Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 11, 2019
- Accepted in final form June 3, 2020
- First Published August 14, 2020.
Article Versions
- Previous version (August 14, 2020 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Yun Peng, MD,
- Youming Zhang, MD,
- Zhao Chen, MD,
- Huirong Peng, MS,
- Na Wan, MS,
- Jennifer Zhang, BS,
- Jingyi Tang, MS,
- Puzhi Wang, MD,
- Yue Xie, MD,
- Qiyong Cai, PhD,
- Shaohui Liu, MD,
- Xuewei Zhang, MD,
- Chunrong Wang, MD,
- Hongyu Yuan, MS,
- Tianjiao Li, MS,
- Linlin Wan, MD,
- Yuting Shi, MD,
- Rong Qiu, PhD,
- Thomas Klockgether, MD,
- Beisha Tang, MD,
- Weihua Liao, MD, PhD* and
- Hong Jiang, MD*
- Yun Peng, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Youming Zhang, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Zhao Chen, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
the National Natural Science Foundation of China (No. 81901169)
NONE
NONE
NONE
NONE
NONE
NONE
- Huirong Peng, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Na Wan, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jennifer Zhang, BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jingyi Tang, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Puzhi Wang, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yue Xie, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Qiyong Cai, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Shaohui Liu, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Xuewei Zhang, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chunrong Wang, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. the National Natural Science Foundation of China (No.81901305); 2. the Youth Foundation of Xiangya Hospital (No. 2018Q05).
NONE
NONE
NONE
NONE
NONE
NONE
- Hongyu Yuan, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tianjiao Li, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Linlin Wan, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yuting Shi, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The National Natural Science Foundation of China (to Y Shi )
NONE
NONE
NONE
NONE
NONE
NONE
- Rong Qiu, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. the Natural Science Foundation of Hunan Province (No.2019JJ40363).
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Klockgether, MD,
NONE
NONE
Novartis(commercial)speaker honorarium Bayer (commercial)speaker honorarium
NONE
NONE
NONE
NONE
Biohaven (commercial) consulting fees Roche(commercial) consulting fees UCB (commercial) consulting fees
NONE
NONE
NONE
NONE
BMBF ÂIDSEM-Verbundprojekt. Integrative Datensemantik für Neurodegenerative Forschung, Teilprojekt CÂ, 2016  2021 EU Joint Programme Neurodegenerative Disease Research (JPND) ÂEuropean Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI)Â, 2016  2020 BMG ÂVersorgung von Menschen mit seltenen Erkrankungen (Kinder und Erwachsene) (TRANSLATE-NAMSE), 2017  2020 NIH ÂClinical trial readiness for SCA1 and SCA3 (1U01NS104326-01), 2018  2022
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Beisha Tang, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1、the National Key Research and Development Program of China (No. 2016YFC1306000)
NONE
NONE
NONE
NONE
NONE
NONE
- Weihua Liao, MD, PhD* and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1.the National Key Research and Development Program of China (No. 81671676 ) 2.the Natural Science Foundation of Hunan Province (No. 2017JJ2387 )
NONE
NONE
NONE
NONE
NONE
NONE
- Hong Jiang, MD*
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. the National Key Research and Development Program of China (No. 2016YFC0905100 and 2016YFC0901504)
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (Y.P., Z.C., H.P., N.W., P.W., Y.X., H.Y., T.L., L.W., Y.S., B.T., H.J.), Radiology (Y.Z., J.T., W.L.), and Pathology (C.W.), Health Management Center (S.L., X.Z.), and National Clinical Research Center for Geriatric Diseases (B.T., W.L., H.J.), Xiangya Hospital, and School of Computer Science and Engineering (R.Q.), Laboratory of Medical Genetics (B.T., H.J.), and Key Laboratory of Hunan Province in Neurodegenerative Disorders (B.T., H.J.), Central South University, Changsha, Hunan, China; Department of Human Genetics (J.Z.), Emory University School of Medicine, Atlanta, GA; Institute of Chemical Biology and Nanomedicine (ICBN) (Q.C.), Hunan University, Changsha, Hunan, China; Department of Neurology (T.K.), University of Bonn; and German Center for Neurodegenerative Diseases (DZNE) (T.K.), Bonn, Germany.
- Correspondence
Dr. Jiang jianghong73868{at}126.com or Dr. Liao owenliao{at}csu.edu.cn
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.